Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

JDOC

JPMorgan Healthcare Leaders ETF

Active ETFEquity
Not rated

The JDOC Exchange Traded Fund (ETF) is provided by J.P. Morgan Asset Management. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

$60.72
-$0.091 (-0.15%) yesterday
1:30 PM 09/11/26 Closed
1D price range
$60.72$60.72
52W price range
$50.34$64.69
YTD Perf.
+4.84%
YTD Flows
Annualized volatility
Fund AuM
€7.8M
Share class AuM
€7.8M
TTM Yield
Tracking Error
Tracking Difference
ISIN
US46654Q7658
TER
0.65%
Inception date
11/1/2023
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Sep 11, 2026
-5%0%5%10%JANMARMAYJULSEP
Flows
Join for free to unlock
Data as of 07/31/26
Healthcare
96.82%
Consumer Non-Cyclicals
3.18%
Latest JDOC news

No content available for this fund

FAQ about JDOC

JDOC is a Active ETF. This ETF provides exposure to Other Global Health Care Equities.
JDOC carries a total expense ratio (TER) of 0.65%, indicating the annual cost for holding the fund.
JDOC was introduced to the market on November 1, 2023. It trades on United States
JPMorgan Healthcare Leaders ETF, JDOC, is provided by J.P. Morgan Asset Management. Learn more about J.P. Morgan Asset Management here.
JDOC oversees €7.8M in assets as of September 11, 2026.
JDOC follows a distributing dividend policy, meaning it pays out income to investors. As of September 11, 2026, its 12-month trailing yield was 0.84%.
As of July 31, 2026, JDOC has significant geographic allocations in USA, United Kingdom and Switzerland.
As of July 31, 2026, JDOC focuses largely on Healthcare and Consumer Non-Cyclicals.
As of July 31, 2026, JDOC holds 57 positions in its portfolio, with 61.77% of assets concentrated in its top 15 holdings.
As of July 31, 2026, JDOC top three holdings include Eli Lilly & Co., AbbVie, Inc. and UnitedHealth Group, Inc..
The base currency of JDOC is USD.
Data as of 07/31/26
Eli Lilly & Co.
8.05%
AbbVie, Inc.
7.99%
UnitedHealth Group, Inc.
6.22%
Johnson & Johnson
4.97%
Merck & Co., Inc.
4.81%
AstraZeneca PLC
3.75%
Thermo Fisher Scientific, Inc.
3.62%
Bristol Myers Squibb Co.
3.40%
CVS Health Corp.
3.18%
Abbott Laboratories
3.06%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight